October 20-22, 2006, McShain Lounge, McCarthy Hall, Georgetown University, Washington, DC, USA
Medical researchers often discover that their subjects are afflicted
with diseases and conditions other than the disease or condition under
study. There is no settled ethical guidance on when medical researchers
or research sponsors have a responsibility to provide “ancillary
care”—care for these additional diseases or conditions.
Drawing together bioethicists, medical researchers, legal experts, economists,
and health policy experts from around the world, this workshop explored
current ancillary-care practices and needs, debated alternative principled
approaches to ancillary-care obligations, and examined the legal, economic,
and policy issues pertaining to working out guidelines on this neglected
topic in the ethics of medical research.
Consensus paper: With the participation of all but
two of the workshop’s speakers (whose schedules did not permit
them to participate), a paper expressing the consensus of the workshop
has now been published in PLoS Medicine 5(5): e90
doi:10.1371/journal.pmed.0050090
Workshop speakers included:
| Roger
Brownsword, King’s College, London (UK) |
| Alexander
M. Capron, University Professor, Scott H. Bice Chair in Healthcare
Law, Policy and Ethics, and Professor of Law and Medicine at USC. |
| Richard
Chaisson, MD, Professor and Director, Center for TB Research,
Johns Hopkins University |
| Michael D. Clayman, Vice President,
Lilly Research Laboratories (USA) |
| Peter
B. Corr, PhD, Senior Vice President for Science and Technology,
Pfizer Inc. (USA) |
| Stephen
DeCherney, MD, MPG, President, Global Clinical Research Organization,
Quintiles, Inc. (USA) |
| Christine
Grady, PhD, RN, Department of Clinical Bioethics, NIH (USA)
Elizabeth S. Higgs, MD, NIAID, NIH (USA) |
| Elizabeth S. Higgs, MD, MIA, DTM&H, Division of Clinical Research,
NIAID, NIH |
| Dr. Nandini K. Kumar, Division
of Basic Medical Sciences, Traditional Medicine and Bio-Medical
Ethics, Indian Council of Medical Research |
| Reidar
Lie, MD, PhD, Department of Clinical Bioethics, NIH (USA) |
| Maria
Merritt, PhD, Berman Bioethics Institute, Johns Hopkins University
(USA) |
| Prof. Malcolm
Molyneux, Director, Malawi-Liverpool-Wellcome Trust Clinical
Research Programme, Blantyre, Malawi |
| Beyene Petros, D.Sc., Associate Professor
of Biomedical Sciences, Department of Biology, Addis Ababa University;
member of the Council of People's Representatives (Ethiopia) |
| Henry
S. Richardson, PhD, JD, MPP, Georgetown University (USA) |
| Jeremy
Sugarman, MD, MPH, Professor of Bioethics and Medicine, Johns
Hopkins University |
| Sandy
Thomas, Executive Director, Nuffield Council (UK) |
This Workshop was sponsored by the Reflective Engagement Initiative
at Georgetown University, with additional support from Georgetown University's
Department of Philosophy, the Kennedy Institute of Ethics, and the PhRMA
Foundation.
|
